Related Experiment Videos
Gestational trophoblastic disease.
1Department of Gynecology, Lahey Clinic Medical Center, Burlington, Massachusetts 01805, USA.
Obstetrics and Gynecology Clinics of North America
|January 5, 2002
Summary
Gestational trophoblastic disease (GTD) is treatable with chemotherapy, offering remission for advanced cases. Women with a history of GTD can have successful future pregnancies with no increased risk of birth defects.
Area of Science:
- Gynecology
- Oncology
- Reproductive Medicine
Background:
- Gestational trophoblastic disease (GTD) encompasses a range of conditions from molar pregnancy to choriocarcinoma.
- Advanced GTD poses significant challenges but is increasingly manageable.
Purpose of the Study:
- To review the management and reproductive outcomes for patients with gestational trophoblastic neoplasia (GTN).
- To assess the risks associated with future pregnancies after GTN and chemotherapy.
Main Methods:
- Literature review of studies on GTD management and outcomes.
- Analysis of data regarding pregnancy complications and congenital anomalies post-GTN treatment.
Main Results:
- Combination chemotherapy offers high remission rates for advanced GTD.
- No increased risk of pregnancy complications or congenital anomalies observed in offspring of treated patients.
- Patients with a history of molar pregnancy have an increased risk of recurrence (1% after one, up to 23% after two).
Conclusions:
- GTN is a highly curable malignancy with effective chemotherapy.
- Reproductive future is generally positive, with no increased risk of birth defects.
- Patients require counseling on recurrence risks and the importance of early medical attention in subsequent pregnancies.